Sponsor Pipeline

Japanese Foundation for Cancer Research Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07190443 Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast… Breast Cancer Recruiting
Disease Areas
Get alerts when Japanese Foundation for Cancer Research's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free